Preclinical characterization of a reversible XPO1 inhibitor for cancer therapy. (nature.com)

Authors: Van Hauwenhuyse J … Daelemans D Journal: Nature Communications Published: 2026-07-22 DOI: https://doi.org/10.1038/s41467-026-75741-y